Free ACR Calculator — Check Your Kidney Health Instantly

What Is the Albumin-to-Creatinine Ratio (ACR)?

The Albumin-to-Creatinine Ratio, commonly referred to as ACR or UACR (Urine Albumin-to-Creatinine Ratio), is a critical diagnostic test used primarily to screen for early signs of kidney damage. To fully grasp what this ratio represents, it is important to understand its two components: albumin and creatinine.

Albumin is a type of protein that is abundantly present in human blood. It performs numerous essential functions, including maintaining oncotic pressure (which keeps fluid from leaking out of blood vessels into surrounding tissues) and transporting various substances such as hormones, vitamins, and medications throughout the body. Healthy kidneys act as a highly sophisticated filtration system. The glomeruli—tiny networks of blood vessels inside the kidneys—allow waste products and excess water to pass into the urine while retaining vital components like red blood cells and larger proteins like albumin. When the kidneys are functioning optimally, very little to no albumin escapes into the urine. However, when the filtering units of the kidneys are damaged or under excessive stress, they can become "leaky," allowing albumin to spill into the urine. This condition is known as albuminuria.

Creatinine, on the other hand, is a metabolic byproduct generated from the normal breakdown of muscle tissue. It is produced at a relatively constant rate depending on an individual's muscle mass. Healthy kidneys filter creatinine out of the blood and excrete it into the urine at a steady pace. Because its excretion rate is remarkably stable over the course of a day, creatinine serves as an excellent reference point or baseline to evaluate the concentration of other substances in a urine sample.

The Albumin-to-Creatinine Ratio compares the amount of albumin to the amount of creatinine in a single urine sample. Why not just measure albumin alone? The concentration of any substance in a random urine sample can vary drastically depending on a person's hydration status. If you drink a lot of water, your urine becomes dilute, and the albumin concentration might falsely appear low. If you are dehydrated, your urine becomes concentrated, potentially making albumin levels look artificially high. By dividing the albumin concentration by the creatinine concentration, the ACR formula corrects for variations in urine concentration, providing a highly accurate estimation of the total amount of albumin being excreted over a 24-hour period without the inconvenience of collecting urine for a full day and night.

Why ACR Testing Matters for Kidney Health

Chronic Kidney Disease (CKD) is notoriously recognized as a "silent killer." In its early stages, it rarely presents with noticeable symptoms. Individuals can lose a significant portion of their kidney function before feeling unwell. By the time symptoms such as swelling, fatigue, or changes in urination occur, the kidney damage is often advanced and irreversible. This is where the profound importance of ACR testing becomes evident.

The presence of albumin in the urine is frequently the earliest indicator of kidney disease, manifesting long before there is any detectable decline in the Glomerular Filtration Rate (GFR), which measures overall kidney function. Identifying this early damage provides a critical window of opportunity for medical intervention. When albuminuria is detected early, healthcare providers can implement strategies—such as blood pressure management, blood sugar control, and specific medications—that can slow down, halt, or in some cases, even reverse the progression of kidney damage.

ACR testing is particularly crucial for two high-risk populations: people with diabetes and people with hypertension (high blood pressure). Diabetes is the leading cause of CKD worldwide. Chronically elevated blood sugar levels can damage the delicate blood vessels in the kidneys over time, a condition known as diabetic nephropathy. The American Diabetes Association strongly recommends that individuals with type 2 diabetes undergo an annual ACR test starting at the time of diagnosis, and those with type 1 diabetes should begin annual screening five years after their diagnosis.

Hypertension is the second leading cause of kidney failure. High blood pressure forces the heart to work harder and places immense strain on blood vessels throughout the body, including the tiny vessels in the kidneys. This sustained pressure damages the nephrons (the filtering units), causing them to leak protein. Conversely, damaged kidneys are less effective at regulating blood pressure, creating a vicious cycle where hypertension causes kidney damage, which in turn exacerbates hypertension. Regular ACR monitoring allows for the timely detection of hypertensive kidney damage, guiding physicians in optimizing blood pressure therapy to protect renal function.

Furthermore, ACR is not just a marker of kidney health; it is a powerful predictor of overall disease progression. Studies have consistently shown that higher levels of albuminuria correlate strongly with a faster decline in kidney function and an increased risk of eventually requiring dialysis or a kidney transplant.

How to Read and Interpret Your ACR Results

Understanding your ACR results is vital for assessing your kidney health and determining the necessary steps for management. The result is typically reported in milligrams of albumin per gram of creatinine (mg/g) or milligrams of albumin per millimole of creatinine (mg/mmol), depending on regional standard units. In the United States, mg/g is the standard measurement. The results fall into three distinct categories based on established clinical guidelines:

Normal to Mildly Increased (< 30 mg/g)

An ACR value of less than 30 mg/g is considered normal. This indicates that your kidneys are effectively retaining protein in the bloodstream and that the glomerular filtration barrier is intact. For most healthy adults, the actual value will be well below 10 mg/g. If your result falls into this category, it generally means there is no evidence of significant kidney damage at this time. However, routine monitoring should continue based on your age, health status, and presence of risk factors like diabetes or high blood pressure.

Moderately Increased Albuminuria (30 to 300 mg/g)

An ACR value between 30 and 300 mg/g indicates moderately increased albuminuria. Historically, this range was referred to as "microalbuminuria." This terminology has largely been phased out by major medical organizations, such as KDIGO, in favor of "moderately increased" to avoid the misconception that the albumin itself is microscopic; rather, it refers to the small but abnormal quantity of albumin leaking into the urine. A result in this range is often the earliest clinical sign of kidney damage, particularly in individuals with diabetes (early diabetic nephropathy). At this stage, the kidneys are starting to show signs of strain, but the damage is often early enough that aggressive management of underlying conditions can stabilize kidney function and potentially bring the ACR levels back down.

Severely Increased Albuminuria (> 300 mg/g)

An ACR value exceeding 300 mg/g represents severely increased albuminuria, previously known as "macroalbuminuria" or clinical proteinuria. This level indicates substantial damage to the kidney's filtering units. When albumin is leaking at this magnitude, the risk of progressive Chronic Kidney Disease is significantly heightened. Individuals in this category are at a much greater risk of experiencing a rapid decline in GFR and eventually developing End-Stage Renal Disease (ESRD). Intensive medical therapy and close supervision by a nephrologist (kidney specialist) are imperative to manage the condition, preserve remaining kidney function, and mitigate cardiovascular risks.

Understanding the KDIGO Classification System

The Kidney Disease: Improving Global Outcomes (KDIGO) organization provides the international gold standard for classifying and staging Chronic Kidney Disease. The KDIGO framework does not look at GFR or ACR in isolation; instead, it combines both measurements into a comprehensive risk matrix. This two-dimensional approach provides a much more accurate prognosis regarding the risk of CKD progression, kidney failure, and cardiovascular mortality.

The KDIGO system divides GFR into six categories (G1 through G5, with G3 split into G3a and G3b) and albuminuria into three categories (A1, A2, and A3):

• A1 (Normal to mildly increased): ACR < 30 mg/g
• A2 (Moderately increased): ACR 30 - 300 mg/g
• A3 (Severely increased): ACR > 300 mg/g

When these categories are plotted on a grid, they create a "heat map" of risk. Green areas indicate low risk (assuming no other markers of kidney disease). Yellow areas denote moderate risk. Orange areas indicate high risk, and red areas signify very high risk. For example, a patient with a mildly reduced GFR of 75 (Category G2) but an ACR of 400 mg/g (Category A3) is actually at a higher risk for CKD progression and cardiovascular events than a patient with a lower GFR of 50 (Category G3a) who has a normal ACR of 10 mg/g (Category A1).

This integrated KDIGO risk assessment emphasizes that albuminuria is a profoundly important independent risk factor. It dictates how aggressively blood pressure should be controlled, which specific medications (like RAAS blockade or SGLT2 inhibitors) should be prescribed, and how frequently a patient should be monitored by healthcare professionals.

What Causes Elevated ACR

A persistently elevated ACR is rarely an isolated phenomenon; it is almost always secondary to an underlying systemic condition or localized kidney disease that damages the delicate filtering barrier of the glomerulus. The most common and significant causes include:

• Diabetes Mellitus: Both Type 1 and Type 2 diabetes are the predominant drivers of elevated ACR globally. Chronic hyperglycemia leads to glycation of proteins, oxidative stress, and increased pressure within the glomerulus, eventually compromising the structural integrity of the kidney filters.
• Hypertension (High Blood Pressure): Sustained high blood pressure forces the delicate capillaries in the kidneys to endure chronic physical stress. Over time, these blood vessels become thickened, hardened, and ultimately leaky, permitting protein to escape.
• Glomerulonephritis: This is a group of diseases characterized by inflammation of the glomeruli. Conditions such as IgA nephropathy, focal segmental glomerulosclerosis (FSGS), and membranous nephropathy can directly attack the filtration barrier, often resulting in sudden and severe albuminuria.
• Autoimmune Diseases: Systemic conditions like Systemic Lupus Erythematosus (SLE) can cause lupus nephritis, where the body's immune system mistakenly attacks the kidneys, leading to inflammation and protein leakage.
• Cardiovascular Disease: There is a complex, bidirectional relationship between the heart and the kidneys. Heart failure and atherosclerosis can reduce blood flow to the kidneys, causing ischemic damage that manifests as albuminuria.
• Obesity: Significant excess body weight increases the metabolic demand on the kidneys, leading to glomerular hyperfiltration. This increased workload can physically stretch and damage the podocytes (specialized cells in the kidney filter), causing protein leakage.
• Medications and Toxins: Chronic use of certain medications, particularly nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, can induce kidney injury. Exposure to heavy metals or contrast dyes used in certain imaging studies can also temporarily or permanently impair kidney function.

It is also important to recognize that transient (temporary) elevations in ACR can occur due to benign or acute factors. These include severe dehydration, high fevers, intense or prolonged physical exertion, urinary tract infections, and even the simple act of standing upright for long periods (orthostatic proteinuria). Because of these transient factors, a single elevated ACR result does not confirm chronic kidney disease; it must be persistently elevated across multiple tests over several months.

How the ACR Test Is Performed

One of the greatest advantages of the ACR test is its simplicity and convenience for the patient. Historically, measuring urine protein required collecting all urine produced over a full 24-hour period, a cumbersome and error-prone process. The ACR relies on a "spot" urine sample, meaning a single, randomly collected sample of urine.

While a spot urine sample can be collected at any time of day, medical guidelines often recommend a "first-morning void." This is the very first urine produced after waking up. First-morning samples are preferred because they tend to be highly concentrated and are less influenced by factors such as hydration variations, physical activity, or dietary intake that occur throughout the day, providing the most reliable and reproducible baseline measurement.

During the collection process, patients are typically advised to provide a "clean-catch, midstream" sample to prevent contamination from bacteria or cells on the surrounding skin. The sample is then sent to a laboratory where specialized equipment measures both the absolute concentration of albumin and the absolute concentration of creatinine. The laboratory's computer systems then calculate the ratio, which is reported back to the healthcare provider. In recent years, Point-of-Care (POC) testing devices have also been developed, allowing clinicians to measure ACR directly in the clinic with a small drop of urine, providing immediate results to guide treatment decisions during a routine visit.

ACR vs eGFR — How They Work Together

When assessing kidney health, physicians rely on two primary biomarkers: the Albumin-to-Creatinine Ratio (ACR) and the estimated Glomerular Filtration Rate (eGFR). While both provide critical information about the kidneys, they measure entirely different aspects of kidney function, and understanding how they complement each other is essential.

The eGFR is a mathematical estimate of how efficiently the kidneys are filtering waste (specifically creatinine) out of the blood. It gives an overarching picture of the kidney's overall filtering capacity. You can think of eGFR as a measure of the kidney's "plumbing flow rate." A declining eGFR indicates that the total functioning mass of the kidney is decreasing.

In contrast, the ACR measures structural damage to the kidney's filters. It evaluates the integrity of the filtration barrier. Using the plumbing analogy, ACR detects "leaks in the pipes."

Relying on eGFR alone can be misleading, particularly in the early stages of kidney disease. In conditions like early diabetic nephropathy, the kidneys may undergo a phase of hyperfiltration, where the eGFR actually appears normal or even higher than normal, falsely suggesting excellent kidney health. However, during this same early phase, the structural damage is already occurring, and the ACR will be elevated. Therefore, ACR acts as an early warning system, detecting structural damage months or years before the eGFR begins to drop.

Conversely, in advanced age or in certain specific types of kidney disease, a patient might experience a gradual decline in eGFR (reduced filtering capacity) without significant protein leakage (normal ACR). Because these two tests assess different physiological parameters, current clinical guidelines mandate that both eGFR and ACR must be evaluated concurrently to obtain a complete, accurate assessment of an individual's kidney health and to accurately assign a KDIGO risk category.

ACR in Different Populations

The interpretation of ACR can be influenced by demographic and physiological factors, necessitating a nuanced approach in certain populations:

Age: As individuals age, there is often a natural, age-related decline in overall muscle mass, which can lead to slightly lower baseline creatinine excretion. Additionally, mild elevations in albuminuria become more common in the elderly, often reflecting generalized vascular aging rather than an acute kidney disease process. Clinicians must weigh these factors when interpreting borderline ACR results in older adults.

Biological Sex: Men generally possess a higher proportion of muscle mass compared to women. Consequently, men naturally excrete more creatinine into their urine on a daily basis. Because creatinine is the denominator in the ACR formula, a woman with the exact same absolute amount of albumin in her urine as a man will mathematically have a higher ACR result. Some specialized diagnostic guidelines provide slightly different ACR cut-off thresholds for men and women to account for this physiological variance.

Pregnancy: Pregnancy induces profound physiological changes in kidney function. Blood volume expands, and the kidneys must filter significantly more blood, leading to a state of normal hyperfiltration. It is entirely normal for pregnant women to excrete slightly more protein than non-pregnant individuals. However, a sudden, substantial spike in albuminuria, particularly in the second or third trimester, is a major red flag. When accompanied by high blood pressure, an elevated ACR is a key diagnostic criterion for preeclampsia, a serious and potentially life-threatening complication of pregnancy.

Pediatrics: While routine ACR screening is not performed on all healthy children, it is a vital tool for children with chronic conditions like Type 1 diabetes, obesity, or a history of congenital kidney structural anomalies. Normal ACR values in young children can fluctuate slightly more than in adults, but the general threshold of < 30 mg/g remains a standard reference point for clinical evaluation.

Managing Elevated ACR — Lifestyle and Medical Interventions

Receiving a lab report with an elevated ACR can be concerning, but it is highly actionable. Medical science has made tremendous strides in identifying therapies that can protect the kidneys and reduce albuminuria. Management typically involves a multifaceted approach combining lifestyle modifications with targeted pharmacological treatments.

Dietary Modifications

Diet plays a foundational role in kidney protection. One of the most impactful changes is reducing dietary sodium (salt). Excessive sodium intake drives up blood pressure, increasing the physical pressure inside the glomeruli and worsening protein leakage. The National Kidney Foundation generally recommends limiting sodium to less than 2,300 mg per day, though some patients may require even stricter limits. Furthermore, moderating protein intake is often advised. While protein is essential for life, digesting large amounts of animal protein generates metabolic waste that forces the kidneys to work harder (hyperfiltration). Transitioning to a diet that incorporates more plant-based proteins can reduce this workload and gently lower ACR levels.

Blood Pressure and Blood Sugar Control

Strict control of blood pressure is perhaps the single most critical intervention for reducing albuminuria. The target blood pressure for individuals with elevated ACR is typically lower than for the general population, often aiming for less than 130/80 mmHg. For individuals with diabetes, maintaining optimal blood glucose control (measured by the A1C test) is equally imperative. Chronic high blood sugar damages the blood vessels in the kidneys; tightly managing glucose prevents further vascular damage and can stabilize the progression of albuminuria.

Targeted Medications

Several classes of medications have proven highly effective in directly reducing ACR and protecting kidney function:

• ACE Inhibitors and ARBs: Angiotensin-Converting Enzyme (ACE) inhibitors (e.g., lisinopril, ramipril) and Angiotensin II Receptor Blockers (ARBs) (e.g., losartan, valsartan) are the cornerstone of treatment for albuminuria. They do more than just lower systemic blood pressure; they specifically dilate the efferent arteriole (the exit blood vessel) of the glomerulus. This action significantly reduces the pressure inside the filtering unit, immediately reducing the amount of albumin forced through the damaged filter.
• SGLT2 Inhibitors: Originally developed as diabetes medications, Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors (e.g., empagliflozin, dapagliflozin) have revolutionized nephrology. Extensive clinical trials have demonstrated that these drugs provide profound kidney protection and dramatically lower ACR in patients with CKD, regardless of whether they have diabetes. They work by modifying pressure dynamics within the kidneys and reducing cellular stress.
• Non-steroidal Mineralocorticoid Receptor Antagonists (MRAs): Newer medications, such as finerenone, have emerged as powerful tools. They block specific hormonal pathways that cause inflammation and fibrosis (scarring) within the kidneys, offering an additional layer of protection to reduce albuminuria and slow CKD progression.

Monitoring ACR Over Time

A single test provides a snapshot, but monitoring ACR over time reveals the true trajectory of kidney health. Because transient factors like exercise, fever, or dehydration can temporarily elevate albumin levels, an initial high ACR result is rarely used in isolation to diagnose Chronic Kidney Disease. Current guidelines stipulate that the elevation must be persistent—typically confirmed by at least two out of three positive tests conducted over a three-to-six-month period.

Once a diagnosis is established and treatment begins, serial ACR monitoring becomes an essential metric of therapeutic success. A significant reduction in ACR (e.g., a 30% or greater decrease from baseline) is a highly encouraging sign. It indicates that the prescribed interventions (such as ACE inhibitors or SGLT2 inhibitors) are effectively reducing the stress on the glomeruli and mitigating the risk of kidney failure. Conversely, if ACR levels continue to climb despite treatment, it signals that the current regimen is insufficient and that the disease process is aggressive, prompting the healthcare provider to intensify therapy or seek specialized consultation.

When to See a Doctor About Your ACR Results

While an online calculator provides valuable preliminary insights, it is never a substitute for professional medical evaluation. You should promptly schedule an appointment with your healthcare provider if you encounter any of the following scenarios:

• Your calculated ACR consistently falls above 30 mg/g.
• You have established risk factors, such as diabetes, hypertension, or a strong family history of kidney disease, and you have not had an ACR test in the past year.
• You notice visible changes in your urine, such as it appearing unusually frothy or foamy (a classic physical sign of high protein content), or if it appears dark, tea-colored, or bloody.
• You experience systemic symptoms of advanced kidney impairment, such as unexplained swelling (edema) in your legs, ankles, or around your eyes, persistent fatigue, nausea, or a metallic taste in your mouth.

If your ACR is found to be exceptionally high (e.g., well above 300 mg/g) or if it is rapidly increasing alongside a declining eGFR, your primary care physician will likely refer you to a nephrologist. A nephrologist is a specialist equipped to investigate complex kidney disorders, perform specialized diagnostics (like a kidney biopsy, if necessary), and implement advanced treatment protocols.

Frequently Misunderstood Aspects of ACR Testing

There are several common misconceptions surrounding ACR and kidney testing that can lead to unnecessary anxiety or, conversely, a dangerous lack of concern:

Myth: A normal eGFR means my kidneys are perfectly healthy.
Fact: As discussed, eGFR measures overall filtration capacity. You can have a normal eGFR but still have structural kidney damage leaking large amounts of protein (high ACR). An elevated ACR is often the very first sign of trouble, occurring years before eGFR begins to drop.

Myth: Only people with diabetes need an ACR test.
Fact: While it is mandatory for diabetic care, ACR testing is also crucial for individuals with hypertension, cardiovascular disease, obesity, and those with a family history of kidney disease. It is a broad spectrum marker of vascular and renal health.

Myth: High protein in the urine means I should eat more protein to replace it.
Fact: This is a dangerous misconception. The protein lost in the urine is structurally significant for kidney health, but increasing dietary protein actually forces the kidneys to work harder to excrete the metabolic waste of protein digestion. This increased workload (hyperfiltration) accelerates kidney damage and worsens the protein leak. A moderate or even restricted protein diet is usually recommended.

Myth: A single high ACR result means I have chronic kidney disease.
Fact: Because acute illnesses, vigorous exercise, or temporary dehydration can cause transient spikes in albuminuria, a diagnosis of CKD requires that the ACR elevation be persistent over at least three months.

The Science Behind Albuminuria

To appreciate the significance of ACR, one must delve into the microscopic anatomy of the kidney. The human body contains roughly two million nephrons, equally divided between the two kidneys. At the head of each nephron is a glomerulus, a highly specialized, tufted network of microscopic capillaries.

The blood enters the glomerulus under pressure, pushing fluid and small molecules through a complex three-layered filtration barrier. This barrier consists of the fenestrated endothelial cells of the capillary, the glomerular basement membrane, and highly specialized epithelial cells called podocytes. Podocytes possess long, foot-like projections that interlock, creating tiny "slit diaphragms."

This barrier is meticulously designed to restrict the passage of large macromolecules, particularly albumin. It does this based on both size and electrical charge. Albumin is a relatively large molecule and carries a negative electrical charge. The components of the glomerular barrier are also negatively charged. Because like charges repel, the healthy kidney naturally repels albumin, keeping it in the bloodstream.

When diseases like diabetes or hypertension strike, they induce mechanical stress, inflammation, and oxidative damage to this delicate barrier. The podocytes may become injured, lose their intricate structure, or even detach from the membrane. The negative charge of the barrier may be neutralized. When these protective mechanisms fail, albumin slips through the compromised filter and into the urinary space, resulting in albuminuria. Measuring ACR is essentially quantifying the extent of microscopic damage to billions of podocytes and the glomerular basement membrane.

ACR and Cardiovascular Risk

One of the most profound paradigm shifts in modern medicine is the recognition that the kidneys and the cardiovascular system are inextricably linked. An elevated ACR is not merely an indicator that the kidneys are in distress; it is a blaring siren warning of systemic cardiovascular danger.

The blood vessels in the kidneys are a window to the microvascular system of the entire body. If the delicate capillaries in the glomeruli are sustaining damage and leaking protein, it is virtually guaranteed that similar endothelial dysfunction and vascular damage are occurring in the blood vessels supplying the heart, the brain, and the extremities.

Extensive epidemiological research has irrefutably demonstrated that as ACR levels increase, the risk of experiencing a major cardiovascular event—such as a myocardial infarction (heart attack), stroke, or heart failure—skyrockets. In fact, for many patients with early-stage chronic kidney disease, the statistical likelihood of dying from a cardiovascular event is significantly higher than the likelihood of their disease progressing to the point of requiring dialysis. Therefore, an elevated ACR commands immediate, aggressive intervention to mitigate cardiovascular risk, prioritizing lipid management, blood pressure control, and the cessation of smoking.

Future Directions in Albuminuria Testing

The field of nephrology is rapidly evolving, and while ACR remains the gold standard for early detection, researchers are continuously exploring novel ways to enhance diagnosis and monitoring. Advancements in urinary biomarkers are a major area of focus. Scientists are investigating other specific proteins and molecules excreted in the urine (such as NGAL, KIM-1, and various microRNAs) that might indicate different specific types of kidney stress or localize the exact site of injury within the nephron with even greater precision than albumin.

Furthermore, technology is democratizing access to testing. The development of highly accurate, smartphone-integrated point-of-care testing for ACR is progressing. In the near future, patients may be able to reliably monitor their ACR at home using a smartphone camera and a specialized dipstick, transmitting the data securely to their healthcare team. This would facilitate tighter monitoring and faster adjustments to therapeutic regimens, empowering patients to take an active, daily role in preserving their kidney health.

Sources and References

The information and medical guidelines synthesized in this comprehensive overview are derived from the most authoritative bodies in nephrology and internal medicine. The risk categorization and staging frameworks rely heavily on the clinical practice guidelines published by KDIGO (Kidney Disease: Improving Global Outcomes). Diagnostic and screening recommendations, particularly concerning diabetic nephropathy, are aligned with the standards of medical care established by the American Diabetes Association (ADA) and the National Kidney Foundation (NKF). Insights regarding cardiovascular correlations and management strategies reflect consensus statements from the American Heart Association (AHA) and research sponsored by the National Institutes of Health (NIH). All content is presented for informational purposes and reflects the current evidence-based consensus in the medical community.

Conclusion

The Albumin-to-Creatinine Ratio (ACR) is a simple, non-invasive, yet extraordinarily powerful diagnostic tool. By accurately quantifying the microscopic leakage of protein from the kidneys, it provides one of the earliest and most reliable warnings of impending kidney damage and elevated cardiovascular risk. Whether you are living with diabetes, managing high blood pressure, or simply taking proactive steps toward longevity, understanding your ACR is a fundamental component of comprehensive health management. We encourage you to utilize our free calculator as an initial assessment, but more importantly, we urge you to engage in open, informed discussions with your healthcare provider about your kidney health, ensuring that your vital filtration system is protected for decades to come.